Search results
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 23 hours agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling ...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 1 week agoAdenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the...
Very rare COVID vaccine-related blood clots share genes with condition linked to common cold
FierceBiotech· 1 week agoThe rare, deadly blood clots triggered by an autoimmune response to the COVID-19 vaccines from...
J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
Zacks via Yahoo Finance· 1 week agoJNJ’s key areas of focus include immunology, infectious diseases & vaccines, neuroscience,...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 1 week agoJ&J’s single-dose COVID-19 vaccine generated sales of $25 million in the quarter, down 96.6% year...
2 Supercharged Dividend Stocks to Buy and Hold for Years
Motley Fool via Yahoo Finance· 2 weeks agoJohnson & Johnson has 62 years in a row of dividend increases to its name at this point. J&J's...
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 2 weeks agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
3 Healthcare Stocks to Buy Now: May 2024
InvestorPlace· 3 days agoIt’s a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the...